Pefloxacin
J01M - Quinolone antibacterials
ATC J01MA03
Small molecule
JFDA label: Peflox- 400 f/c tablets
Mechanism of Action
Inhibitor of Bacterial DNA gyrase — Bacterial DNA gyrase inhibitor; Inhibitor of Topoisomerase IV — Topoisomerase IV inhibitor
| Target | Action | Gene / class |
| Bacterial DNA gyrase efficacy |
INHIBITOR |
|
| Topoisomerase IV efficacy |
INHIBITOR |
|
Indications
Approved
- Bacterial Infections — bacterial disease
Class profile
| gramStatus | Both |
| spectrumBreadth | Moderate |
| atypicalCoverage | No |
| isBactericidal | 1 |
| moaCategory | DNA synthesis inhibitor (topoisomerase II/IV) |
| pdIndex | Concentration-dependent |
| postAntibioticEffect | Prolonged |
| mrsaCoverage | 0 |
| resistanceMechanisms | Target site mutations (gyrA,parC),Active efflux |
Pregnancy & Lactation
Monitoring
| Efficacy | Culture and susceptibility testing; clinical resolution (temperature, WBC, CRP, procalcitonin) |
| Toxicity | Renal function (dose adjustment in renal impairment); hepatic function for hepatically cleared agents; signs of C. difficile infection (diarrhoea) |
| Clinical pearl | Culture results guide de-escalation to narrower-spectrum therapy. Review antibiotic appropriateness at 48–72 h (antimicrobial stewardship). |
| Counseling | Complete the full course. Report persistent diarrhoea, rash, or lack of improvement after 48–72 h. |
Chemistry & Properties
| Formula | C17H20FN3O3 |
| Molecular weight | 333.36 g/mol |
| IUPAC name | 1-ethyl-6-fluoro-7-(4-methylpiperazin-1-yl)-4-oxoquinoline-3-carboxylic acid |
| CAS | 70458-92-3 |
| PubChem CID | 51081 |
| InChIKey | FHFYDNQZQSQIAI-UHFFFAOYSA-N |
| logP | 1.61 (XLogP 0.3) |
| Polar surface area | 65.78 Ų |
| H-bond acceptors / donors | 5 / 1 |
| Drug-likeness (QED) | 0.92 |
| Lipinski violations | 0 |
SMILES
CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCN(C)CC3)cc21
Biology & Pharmacokinetics
Pharmacokinetics
| BBB penetrant | Yes (logBB -0.16) |
Transporters
BCRP (Inhibitor)BSEP (Inhibitor)BSEP (Inhibitor)MRP1 (Inhibitor)MRP2 (Inhibitor)MRP3 (Inhibitor)MRP4 (Inhibitor)OATP1B1 (Inhibitor)OATP1B3 (Inhibitor)OATP1B3 (Inhibitor)P-gp (Inhibitor)P-gp (Substrate)
Registered Products (3)
| Brand | Form / strength | Pack | Agent | Citizen (JOD) |
| Pefloquin Tab
|
Tablet 400 mg |
2 tab pack varies |
Hayat Pharmaceutical Industries CO.PLC/JORDAN |
1.080 |
| Pefloquin Tab
|
Tablet 400 mg |
10 tab pack varies |
Hayat Pharmaceutical Industries CO.PLC/JORDAN |
4.970 |
| Peflox- 400 f/c tablets
|
Tablet 400 mg |
10 tab |
AL-RAM PHARMA.INDUS.CO.LTD/JORDAN |
5.420 |